1431 related articles for article (PubMed ID: 22217193)
21. Blood pressure and glucose control in subjects with diabetes: new analyses from ADVANCE.
Poulter NR
J Hypertens Suppl; 2009 May; 27(1):S3-8. PubMed ID: 19483505
[TBL] [Abstract][Full Text] [Related]
22. Implications of the ADVANCE study for clinical practice.
Zannad F
J Hypertens Suppl; 2008 Sep; 26(3):S29-32. PubMed ID: 19363850
[TBL] [Abstract][Full Text] [Related]
23. Cardiovascular implications of antihyperglycemic therapies for type 2 diabetes.
Ovalle F
Clin Ther; 2011 Apr; 33(4):393-407. PubMed ID: 21635987
[TBL] [Abstract][Full Text] [Related]
24. Reducing cardiovascular disease risk in patients with type 2 diabetes and concomitant macrovascular disease: can insulin be too much of a good thing?
Rensing KL; Reuwer AQ; Arsenault BJ; von der Thüsen JH; Hoekstra JB; Kastelein JJ; Twickler TB
Diabetes Obes Metab; 2011 Dec; 13(12):1073-87. PubMed ID: 21736687
[TBL] [Abstract][Full Text] [Related]
25. [Critical notes on the results of studies (ACCORD, ADVANCE, VADT) of the efficiency of intensive therapy of type 2 diabetes mellitus].
Schwartz V
Klin Med (Mosk); 2011; 89(3):18-20. PubMed ID: 21861397
[TBL] [Abstract][Full Text] [Related]
26. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering.
Pedersen TR
Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729
[TBL] [Abstract][Full Text] [Related]
27. The HOPE Study (Heart Outcomes Prevention Evaluation).
Sleight P
J Renin Angiotensin Aldosterone Syst; 2000 Mar; 1(1):18-20. PubMed ID: 11967789
[TBL] [Abstract][Full Text] [Related]
28. Prevention of macrovascular disease in patients with diabetes mellitus: opportunities for intervention.
Mazzone T
Am J Med; 2007 Sep; 120(9 Suppl 2):S26-32. PubMed ID: 17826043
[TBL] [Abstract][Full Text] [Related]
29. Effects of intensive glucose control on incidence of cardiovascular events in patients with type 2 diabetes: a meta-analysis.
Zhang CY; Sun AJ; Zhang SN; Wu CN; Fu MQ; Xia G; Wang KQ; Zou YZ; Ge JB
Ann Med; 2010 May; 42(4):305-15. PubMed ID: 20429797
[TBL] [Abstract][Full Text] [Related]
30. Sodium-glucose co-transporter 2 inhibitors and the potential for cardiovascular risk reduction in patients with type 2 diabetes mellitus.
Guthrie RM
Postgrad Med; 2013 May; 125(3):21-32. PubMed ID: 23748504
[TBL] [Abstract][Full Text] [Related]
31. New insights from ADVANCE.
Chalmers J; Kengne AP; Joshi R; Perkovic V; Patel A
J Hypertens Suppl; 2007 Jun; 25(1):S23-30. PubMed ID: 17579315
[TBL] [Abstract][Full Text] [Related]
32. [Treatment of diabetes in metabolic syndrome].
Pelikánova T
Vnitr Lek; 2009; 55(7-8):637-45. PubMed ID: 19731868
[TBL] [Abstract][Full Text] [Related]
33. A primary care register for impaired glucose handling (IGH): impact on cardiometabolic profile.
Heald AH; Knapman H; Nair S; Chambers T; Radford D; Rushton T; Anderson SG
Prim Care Diabetes; 2012 Oct; 6(3):213-9. PubMed ID: 22560663
[TBL] [Abstract][Full Text] [Related]
34. An insight into the recent diabetes trials: what is the best approach to prevent macrovascular and microvascular complications?
Konig M; Lamos EM; Stein SA; Davis SN
Curr Diabetes Rev; 2013 Sep; 9(5):371-81. PubMed ID: 23865412
[TBL] [Abstract][Full Text] [Related]
35. Intensive glucose control and cardiovascular outcomes in type 2 diabetes.
Macisaac RJ; Jerums G
Heart Lung Circ; 2011 Oct; 20(10):647-54. PubMed ID: 20807681
[TBL] [Abstract][Full Text] [Related]
36. The Role of Hypoglycemia in Cardiovascular Outcomes in Diabetes.
Paty BW
Can J Diabetes; 2015 Dec; 39 Suppl 5():S155-9. PubMed ID: 26654859
[TBL] [Abstract][Full Text] [Related]
37. ADVANCE: breaking new ground in type 2 diabetes.
Chalmers J; Perkovic V; Joshi R; Patel A
J Hypertens Suppl; 2006 Aug; 24(5):S22-8. PubMed ID: 16936533
[TBL] [Abstract][Full Text] [Related]
38. What matters in ADVANCE and ADVANCE-ON.
Hamet P
Diabetes Obes Metab; 2012 Jan; 14 Suppl 1():20-9. PubMed ID: 22118707
[TBL] [Abstract][Full Text] [Related]
39. Reviewing statin therapy in diabetes--towards the best practise.
Matikainen N; Kahri J; Taskinen MR
Prim Care Diabetes; 2010 Apr; 4(1):9-15. PubMed ID: 20171948
[TBL] [Abstract][Full Text] [Related]
40. Outcome studies in type 2 diabetes.
Hanefeld M
Curr Med Res Opin; 2005; 21 Suppl 1():S41-8. PubMed ID: 15811198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
